Monopolar spindle-one-binder protein 2 regulates the activity of large tumor suppressor/yes-associated protein to inhibit the motility of SMMC-7721 hepatocellular carcinoma cells

  • Authors:
    • Weicheng Zhang
    • Jingyuan Shen
    • Fengming Gu
    • Ying Zhang
    • Wenjuan Wu
    • Jiachun Weng
    • Yuexia Liao
    • Zijing Deng
    • Qing Yuan
    • Lu Zheng
    • Yu Zhang
    • Weigan Shen
  • View Affiliations

  • Published online on: February 5, 2018     https://doi.org/10.3892/ol.2018.7952
  • Pages: 5375-5383
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Accumulating evidence implicates monopolar spindle-one-binder protein (MOB)2 as an inhibitor of nuclear-Dbf2-related kinase (NDR) by competing with MOB1 for interaction with NDR1/2. NDR/large tumor suppressor (LATS) kinases may function similarly to yes‑associated protein (YAP) kinases and be considered as members of the Hippo core cassette. MOB2 appears to serve roles in cell survival, cell cycle progression, responses to DNA damage and cell motility. However, the underlying mechanisms involved remain unclarified. In the present study, it was demonstrated that the knockout of MOB2 by clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated protein 9 promoted migration and invasion, induced phosphorylation of NDR1/2 and decreased phosphorylation of YAP in SMMC‑7721 cells when compared with the blank vector‑transduced cells. By contrast, the overexpression of MOB2 resulted in the opposite results. Mechanistically, MOB2 regulated the alternative interaction of MOB1 with NDR1/2 and LATS1, which resulted in increased phosphorylation of LATS1 and MOB1 and thereby led to the inactivation of YAP and consequently inhibition of cell motility. The results of the present study provide evidence of MOB2 serving a positive role in LATS/YAP activation by activating the Hippo signaling pathway.

References

1 

Hergovich A: MOB control: Reviewing a conserved family of kinase regulators. Cell Signal. 23:1433–1440. 2011. View Article : Google Scholar : PubMed/NCBI

2 

Hergovich A: Regulation and functions of mammalian LATS/NDR kinases: Looking beyond canonical Hippo signalling. Cell Biosci. 3:322013. View Article : Google Scholar : PubMed/NCBI

3 

Hergovich A: The roles of NDR protein kinases in Hippo signalling. Genes (Basel). 7:E212016. View Article : Google Scholar : PubMed/NCBI

4 

Gundogdu R and Hergovich A: The possible crosstalk of MOB2 with NDR1/2 kinases in cell cycle and DNA damage signaling. J Cell Signal. 1:1252016. View Article : Google Scholar : PubMed/NCBI

5 

Kohler RS, Schmitz D, Cornils H, Hemmings BA and Hergovich A: Differential NDR/LATS interactions with the human MOB family reveal a negative role for human MOB2 in the regulation of human NDR kinases. Mol Cell Biol. 30:4507–4520. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Bothos J, Tuttle RL, Ottey M, Luca FC and Halazonetis TD: Human LATS1 is a mitotic exit network kinase. Cancer Res. 65:6568–6575. 2005. View Article : Google Scholar : PubMed/NCBI

7 

Gomez V, Gundogdu R, Gomez M, Hoa L, Panchal N, O'Driscoll M and Hergovich A: Regulation of DNA damage responses and cell cycle progression by hMOB2. Cell Signal. 27:326–339. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Wu W, Zhang X, Qin H, Peng W, Xue Q, Lv H, Zhang H, Qiu Y, Cheng H, Zhang Y, et al: Modulation of tumor cell migration, invasion and cell-matrix adhesion by human monopolar spindle-one-binder 2. Oncol Rep. 33:2495–2503. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

10 

Tamaskovic R, Bichsel SJ, Rogniaux H, Stegert MR and Hemmings BA: Mechanism of Ca2+-mediated regulation of NDR protein kinase through autophosphorylation and phosphorylation by an upstream kinase. J Biol Chem. 278:6710–6718. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Vichalkovski A, Gresko E, Cornils H, Hergovich A, Schmitz D and Hemmings BA: NDR kinase is activated by RASSF1A/MST1 in response to Fas receptor stimulation and promotes apoptosis. Curr Biol. 18:1889–1895. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Zhang L, Tang F, Terracciano L, Hynx D, Kohler R, Bichet S, Hess D, Cron P, Hemmings BA, Hergovich A and Schmitz-Rohmer D: NDR functions as a physiological YAP1 kinase in the intestinal epithelium. Curr Biol. 25:296–305. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Zhang L, Xue G, Grzmil M, Yang Z, Hergovich A, Hollaender GA, Stein JV, Hemmings BA and Matthias P: The kinases NDR1/2 act downstream of the Hippo homolog MST1 to mediate both egress ofthymocytes from the thymus and lymphocyte motility. Sci Signal. 8:ra1002015. View Article : Google Scholar : PubMed/NCBI

14 

Zhang X, George J, Deb S, Degoutin JL, Takano EA, Fox SB; AOCS Study group; Bowtell DD and Harvey KF: The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene. 30:2810–2822. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Liu J, Li J, Li P, Wang Y, Liang Z, Jiang Y, Li J, Feng C, Wang R, Chen H, et al: Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway. Sci Rep. 7:421252017. View Article : Google Scholar : PubMed/NCBI

16 

Yu FX, Zhang Y, Park HW, Jewell JL, Chen Q, Deng Y, Pan D, Taylor SS, Lai ZC and Guan KL: Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 27:1223–1232. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Yang S, Zhang L, Purohit V, Shukla SK, Chen X, Yu F, Fu K, Chen Y, Solheim J, Singh PK, et al: Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3. Oncotarget. 6:36019–36031. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Moroishi T, Park HW, Qin B, Chen Q, Meng Z, Plouffe SW, Taniguchi K, Yu FX, Karin M, Pan D and Guan KL: A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev. 29:1271–1284. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Hayashi H, Higashi T, Yokoyama N, Kaida T, Sakamoto K, Fukushima Y, Ishimoto T, Kuroki H, Nitta H, Hashimoto D, et al: An imbalance in TAZ and YAP expression in hepatocellular carcinoma confers cancer stem cell-like behaviors contributing to disease progression. Cancer Res. 75:4985–4997. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Mo JS, Park HW and Guan KL: The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep. 15:642–656. 2014.PubMed/NCBI

21 

Mo JS, Yu FX, Gong R, Brown JH and Guan KL: Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev. 26:2138–2143. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Harvey KF, Zhang X and Thomas DM: The Hippo pathway and human cancer. Nat Rev Cancer. 13:246–257. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Haskins JW, Nguyen DX and Stern DF: Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration. Sci Signal. 7:ra1162014. View Article : Google Scholar : PubMed/NCBI

24 

Huelter-Hassler D, Tomakidi P, Steinberg T and Jung BA: Orthodontic strain affects the Hippo-pathway effector YAP concomitant with proliferation in human periodontal ligament fibroblasts. Eur J Orthod. 39:251–257. 2017. View Article : Google Scholar : PubMed/NCBI

25 

Oh H and Irvine KD: Yorkie: The final destination of Hippo signaling. Trends Cell Biol. 20:410–417. 2010. View Article : Google Scholar : PubMed/NCBI

26 

Vahid S, Thaper D, Gibson KF, Bishop JL and Zoubeidi A: Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer. Sci Rep. 6:318422016. View Article : Google Scholar : PubMed/NCBI

27 

Hergovich A, Schmitz D and Hemmings BA: The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochem Biophys Res Commun. 345:50–58. 2006. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhang, W., Shen, J., Gu, F., Zhang, Y., Wu, W., Weng, J. ... Shen, W. (2018). Monopolar spindle-one-binder protein 2 regulates the activity of large tumor suppressor/yes-associated protein to inhibit the motility of SMMC-7721 hepatocellular carcinoma cells. Oncology Letters, 15, 5375-5383. https://doi.org/10.3892/ol.2018.7952
MLA
Zhang, W., Shen, J., Gu, F., Zhang, Y., Wu, W., Weng, J., Liao, Y., Deng, Z., Yuan, Q., Zheng, L., Zhang, Y., Shen, W."Monopolar spindle-one-binder protein 2 regulates the activity of large tumor suppressor/yes-associated protein to inhibit the motility of SMMC-7721 hepatocellular carcinoma cells". Oncology Letters 15.4 (2018): 5375-5383.
Chicago
Zhang, W., Shen, J., Gu, F., Zhang, Y., Wu, W., Weng, J., Liao, Y., Deng, Z., Yuan, Q., Zheng, L., Zhang, Y., Shen, W."Monopolar spindle-one-binder protein 2 regulates the activity of large tumor suppressor/yes-associated protein to inhibit the motility of SMMC-7721 hepatocellular carcinoma cells". Oncology Letters 15, no. 4 (2018): 5375-5383. https://doi.org/10.3892/ol.2018.7952